We should pay more attention to renal function before initiation of warfarin therapy

被引：1

作者：

Yamaguchi, Takanori ^{[1
]}

Takahashi, Naohiko ^{[1
]}

机构：

[1] Oita Univ, Fac Med, Dept Cardiol & Clin Examinat, Yufu, Oita 8795593, Japan

来源：

JOURNAL OF CARDIOLOGY | 2015年 / 65卷 / 3-4期

关键词：

Renal impairment; Warfarin; Genotype; ATRIAL-FIBRILLATION; MAJOR HEMORRHAGE; RISK; MANAGEMENT;

D O I：

10.1016/j.jjcc.2014.10.001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：173 / 174

页数：2

共 15 条

[1] Factors affecting bleeding risk during anticoagulant therapy in patients with atrial fibrillation: Observations from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study [J].

DiMarco, JP ;

Flaker, G ;

Waldo, AL ;

Corley, SD ;

Greene, HL ;

Safford, RE ;

Rosenfeld, LE ;

Mitrani, G ;

Nemeth, M .

AMERICAN HEART JOURNAL, 2005, 149 (04) :650-656

[2] Major Hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation [J].

Hylek, Elaine M. ;

Evans-Molina, Carmella ;

Shea, Carol ;

Henault, Lori E. ;

Regan, Susan .

CIRCULATION, 2007, 115 (21) :2689-2696

[3] Effect of impaired renal function on the maintenance dose of warfarin in Japanese patients [J].

Ichihara, Naoaki ;

Ishigami, Tomoaki ;

Umemura, Satoshi .

JOURNAL OF CARDIOLOGY, 2015, 65 (3-4) :178-184

[4] Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing [J].

Johnson, J. A. ;

Gong, L. ;

Whirl-Carrillo, M. ;

Gage, B. F. ;

Scott, S. A. ;

Stein, C. M. ;

Anderson, J. L. ;

Kimmel, S. E. ;

Lee, M. T. M. ;

Pirmohamed, M. ;

Wadelius, M. ;

Klein, T. E. ;

Altman, R. B. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (04) :625-629

[5] A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing [J].

Kimmel, Stephen E. ;

French, Benjamin ;

Kasner, Scott E. ;

Johnson, Julie A. ;

Anderson, Jeffrey L. ;

Gage, Brian F. ;

Rosenberg, Yves D. ;

Eby, Charles S. ;

Madigan, Rosemary A. ;

McBane, Robert B. ;

Abdel-Rahman, Sherif Z. ;

Stevens, Scott M. ;

Yale, Steven ;

Mohler, Emile R., III ;

Fang, Margaret C. ;

Shah, Vinay ;

Horenstein, Richard B. ;

Limdi, Nita A. ;

Muldowney, James A. S., III ;

Gujral, Jaspal ;

Delafontaine, Patrice ;

Desnick, Robert J. ;

Ortel, Thomas L. ;

Billett, Henny H. ;

Pendleton, Robert C. ;

Geller, Nancy L. ;

Halperin, Jonathan L. ;

Goldhaber, Samuel Z. ;

Caldwell, Michael D. ;

Califf, Robert M. ;

Ellenberg, Jonas H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (24) :2283-2293

[6] Warfarin Dosing in Patients With Impaired Kidney Function [J].

Limdi, Nita A. ;

Limdi, Mohit A. ;

Cavallari, Larisa ;

Anderson, Aaron M. ;

Crowley, Michael R. ;

Baird, Melissa F. ;

Allon, Michael ;

Beasley, T. Mark .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (05) :823-831

[7] Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications [J].

Limdi, Nita A. ;

Beasley, T. Mark ;

Baird, Melissa F. ;

Goldstein, Joyce A. ;

McGwin, Gerald ;

Arnett, Donna K. ;

Acton, Ronald T. ;

Allon, Michael .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (04) :912-921

[8] Severe Renal Impairment and Stroke Prevention in Atrial Fibrillation Implications for Thromboprophylaxis and Bleeding Risk [J].

Marinigh, Ricarda ;

Lane, Deirdre A. ;

Lip, Gregory Y. H. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (12) :1339-1348

[9] Risk of major hemorrhage for outpatients treated with warfarin [J].

McMahan, DA ;

Smith, DM ;

Carey, MA ;

Zhou, XH .

JOURNAL OF GENERAL INTERNAL MEDICINE, 1998, 13 (05) :311-316

[10] Bleeding with anticoagulation therapy - Who is at risk, and how best to identify such patients [J].

Palareti, Gualtiero ;

Cosmi, Benilde .

THROMBOSIS AND HAEMOSTASIS, 2009, 102 (02) :268-278

← 1 2 →